{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/49627971"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Accordingly, the present invention provides a method of treating and/or preventing a disease or disorder, in particular a condition associated with altered glutamatergic signalling and/or functions, and/or a condition which can be affected by alteration of glutamate level or signalling, the method comprising the administration of a compound of the general formula (I) as described and defined herei" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "freshpatents.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/410598271"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/49627971"] } } }
